Ron Barkley, president of the Cancer Center Business Development Group, which consults with oncology providers on value-based care arrangements, shares tips.
Leukemia and Lymphoma
CEO of a Pennsylvania-based oncology group shares how participating in a new value-based model is changing the care approach.
Healthcare systems stand to lose $6 million if burned out physicians choose to resign or work elsewhere. Here are some ways to curb burnout and its associated costs.
When caring for cancer patients, improving care coordination in these two areas is key—and it can help reduce healthcare costs.
Genetic testing is playing a growing role in diagnosing and treating diseases, particularly when it comes to certain cancers and rheumatic conditions.
Successful CAR T-cell therapy reimbursement begins with careful payer-provider collaboration and taking these two approaches.
A Stanford expert describes ideal treatment locations, common barriers, and how payers could better support patients and families.
In partnership with the several big-name cancer centers, one company has commenced clinical trials. Find out how this cancer vaccine would work.
The high cost of specialty drugs continues to plague the healthcare industry. Here’s why.
Catherine Bollard, MD, discusses the success rate of CAR T-cell treatments, remaining obstacles, and top payer considerations.